Jordheim LP - Search Results

1

The synergy between alkylating agents and ERCC1-XPF inhibitors is p53 dependent.

Ciniero G, Pedro TM, Dumontet C, Elmenoufy AH, West FG, Weinfeld M, Gentile F, Tuszynski JA, Cros-Perrial E, Jordheim LP. Ciniero G, et al. Among authors: jordheim lp. Fundam Clin Pharmacol. 2025 Feb;39(1):e13043. doi: 10.1111/fcp.13043. Epub 2024 Nov 8. Fundam Clin Pharmacol. 2025. PMID: 39520092

2

Drug resistance to cytotoxic nucleoside analogues.

Jordheim L, Galmarini CM, Dumontet C. Jordheim L, et al. Curr Drug Targets. 2003 Aug;4(6):443-60. doi: 10.2174/1389450033490957. Curr Drug Targets. 2003. PMID: 12866659 Review.

3

Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug.

Jordheim LP, Cros E, Gouy MH, Galmarini CM, Peyrottes S, Mackey J, Perigaud C, Dumontet C. Jordheim LP, et al. Clin Cancer Res. 2004 Aug 15;10(16):5614-21. doi: 10.1158/1078-0432.CCR-04-0506. Clin Cancer Res. 2004. PMID: 15328204

4

Regulation and activity of cytosolic 5'-nucleotidase II. A bifunctional allosteric enzyme of the Haloacid Dehalogenase superfamily involved in cellular metabolism.

Bretonnet AS, Jordheim LP, Dumontet C, Lancelin JM. Bretonnet AS, et al. Among authors: jordheim lp. FEBS Lett. 2005 Jun 20;579(16):3363-8. doi: 10.1016/j.febslet.2005.05.014. FEBS Lett. 2005. PMID: 15946667 Free article. Review.

5

Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells.

Jordheim LP, Guittet O, Lepoivre M, Galmarini CM, Dumontet C. Jordheim LP, et al. Mol Cancer Ther. 2005 Aug;4(8):1268-76. doi: 10.1158/1535-7163.MCT-05-0121. Mol Cancer Ther. 2005. PMID: 16093443

6

Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells.

Jordheim LP, Galmarini CM, Dumontet C. Jordheim LP, et al. Cancer Chemother Pharmacol. 2006 Oct;58(4):547-54. doi: 10.1007/s00280-006-0195-8. Epub 2006 Feb 4. Cancer Chemother Pharmacol. 2006. PMID: 16463058

7

Review of recent studies on resistance to cytotoxic deoxynucleoside analogues.

Jordheim LP, Dumontet C. Jordheim LP, et al. Biochim Biophys Acta. 2007 Dec;1776(2):138-59. doi: 10.1016/j.bbcan.2007.07.004. Epub 2007 Aug 14. Biochim Biophys Acta. 2007. PMID: 17881132 Review.

8

Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues.

Hébrard C, Dumontet C, Jordheim LP. Hébrard C, et al. Among authors: jordheim lp. Cancer Gene Ther. 2009 Jul;16(7):541-50. doi: 10.1038/cgt.2009.25. Epub 2009 Apr 3. Cancer Gene Ther. 2009. PMID: 19343063 Review.

9

Bacterial deoxyribonucleoside kinases are poor suicide genes in mammalian cells.

Hébrard C, Cros-Perrial E, Clausen AR, Dumontet C, Piskur J, Jordheim LP. Hébrard C, et al. Among authors: jordheim lp. Nucleosides Nucleotides Nucleic Acids. 2009 Nov;28(11):1068-75. doi: 10.1080/15257770903368393. Nucleosides Nucleotides Nucleic Acids. 2009. PMID: 20183574

10

Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868.

Jordheim LP, Plesa A, Dreano M, Cros-Perrial E, Keime C, Herveau S, Demangel D, Vendrell JA, Dumontet C. Jordheim LP, et al. Cancer Chemother Pharmacol. 2011 Jul;68(1):97-105. doi: 10.1007/s00280-010-1458-y. Epub 2010 Sep 16. Cancer Chemother Pharmacol. 2011. PMID: 20844879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters